Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$86.88 USD
+2.51 (2.97%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $86.88 0.00 (0.00%) 7:18 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $1.10 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.13 per share. This reflects a positive earnings surprise of 6.19%. Look out for LGND's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $1.10 per share, reflecting a year-over-year decrease of 22.54%.
Earnings History
Price & Consensus
Zacks News for LGND
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services